Endoluminal Vacuum Therapy to Prevent Anastomotic Leakage After Esophagectomy Due to Esophageal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Clinical Trials Related to Esophageal Cancer
Related studies linked through entity extraction aliases.
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First-in-human Interleukin-15-transpresenting Wilms' Tumor Protein 1-targeting Autologous Dendritic Cell Vaccination in Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Liquid Biopsies in Esophageal Cancer
- Status
- RECRUITING
- Phase
- NA
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants With Advanced Unresectable or Metastatic Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of CEA-targeted CAR-T for CEA-positive Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
- Status
- RECRUITING
- Phase
- N/A
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
- Status
- SUSPENDED
- Phase
- PHASE1
EMR Versus ESD for Barrett's Neoplasia
- Status
- RECRUITING
- Phase
- NA
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Treatment Outcomes of Esophageal Cancer
- Status
- RECRUITING
- Phase
- N/A
Pharmacokinetics Study of Larotinib in Subjects With Impaired Hepatic Function
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
AB122 Platform Study
- Status
- RECRUITING
- Phase
- PHASE1
Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered Malignancies
- Status
- AVAILABLE
- Phase
- N/A
Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Sentinel Lymph Node Mapping in Esophageal Cancer Using ICG Dye and NIR Imaging
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA